Company registration number: 09213110
Annual report and unaudited financial statements
for the year ended 30 September 2025
for
Calscience Group Limited
Pages for filing with the Registrar
Company registration number: 09213110
Calscience Group Limited
Balance sheet
as at 30 September 2025
2025 2024
Note £ £ £ £
Fixed assets
Investments 4 - 900,000
- 900,000
Current assets
Debtors 1 499,899
Cash at bank and in hand 2,724 2,347
2,725 502,246
Creditors: amounts falling due within one year
(25) (25)
Net current assets 2,700 502,221
Total assets less current liabilities 2,700 1,402,221
Creditors: Amounts falling due after more than one year
- (15,000)
NET ASSETS 2,700 1,387,221
Capital and reserves
Called up share capital 1,466,001 1,411,001
Profit and loss account (1,463,301) (23,780)
TOTAL EQUITY 2,700 1,387,221
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 30 September 2025.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 09213110
Calscience Group Limited
Balance sheet - continued
as at 30 September 2025
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
These financial statements were approved by the Board of directors and authorised for issue on 5 October 2026 and signed on its behalf by:
Mr I Forbes, Director
5 October 2026
2
Calscience Group Limited
Notes to the financial statements
for the year ended 30 September 2025
1 Company information
Calscience Group Limited is a private company registered in England and Wales. Its registered number is 09213110. The company is limited by shares. Its registered office is 2A-3A Clifton-Crick Sharp & Co Ltd, Market Gate, Pershore, Worcestershire, WR10 1DZ.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Going concern
In preparing these financial statements, the directors have assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company’s ability to continue as a going concern. In making this assessment, the directors take into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The directors consider that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Investments in subsidiaries
Investments in subsidiaries are recognised at cost.
3 Average number of employees
During the year the average number of employees was 5 (2024 - 5).
4 Fixed asset investments
Investments other than loans
Shares in group undertakings and participating interests




£
Cost
At 1 October 2024 900,000
Impairments (900,000)
At 30 September 2025 -
3
Calscience Group Limited
Notes to the financial statements - continued
for the year ended 30 September 2025
4 Fixed asset investments - continued
Investments other than loans - continued
Net book value
At 30 September 2025 -
At 30 September 2024 900,000
5 Asset impairment
Impairment loss £900,000 Bad debts £539,419 Following the year-end the directors of subsidiary Calscience International Limited provided a report detailing business prospects and outstanding liabilities. After due consideration and there being no willingness by the shareholders to make any further investment the Board concluded its investment in the share capital of the subsidiary of £900,000 and the current account of the subsidiary of £539,419 were irrecoverable.


4